75 results
Page 2 of 4
6-K
EX-99.1
qfoat rt7f
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.2
52whf953 z7ckb
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
oe00w3473lw3akco968
25 May 22
Enlivex Awarded Its Third Non-Dilutive Israel Innovation Authority Grant
8:05am
6-K
EX-99.1
9844hl9 ya7a
25 May 22
Enlivex Awarded Its Third Non-Dilutive Israel Innovation Authority Grant
8:05am
6-K
EX-99.1
tunnmem43zljh8fk us
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
l10l8yc8gaboq tza
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
d85odbnk9tfk
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-99.1
5lb6bym
9 Aug 21
Enlivex Announces Second Quarter 2021 Financial Results and Provides a Business Update
8:00am
6-K
EX-99.1
h4sjxjkkcnb4czm
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
6-K
EX-99.2
6plvjff 2t47
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
6-K
EX-99.1
o7t8 791gd
28 May 21
Condensed Consolidated Financial Statements
4:33pm
6-K
EX-99.2
zak7a
28 May 21
Condensed Consolidated Financial Statements
4:33pm
6-K
rb67aw9r yr16
18 May 21
Enlivex Awarded Second Israel Innovation Authority Grant to Support the Clinical Development of Allocetra in Sepsis
8:03am
6-K
EX-99.1
x08vc
18 May 21
Enlivex Awarded Second Israel Innovation Authority Grant to Support the Clinical Development of Allocetra in Sepsis
8:03am
6-K
EX-1.1
gyikbw
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
mvctzu8 5x
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
xiupces183ssyazxe
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-99.2
z8a809e8m7g2
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm